Barriers to new drug development in respiratory disease

Eur Respir J. 2015 May;45(5):1197-207. doi: 10.1183/09031936.00007915.
No abstract available

Publication types

  • Congress
  • Editorial

MeSH terms

  • Animals
  • Asthma / drug therapy
  • Disease Models, Animal
  • Drug Discovery*
  • Drug Evaluation, Preclinical
  • Drug Industry / legislation & jurisprudence
  • Drug Industry / trends*
  • Germany
  • Humans
  • Italy
  • Pulmonary Disease, Chronic Obstructive / drug therapy
  • Respiration Disorders / drug therapy*
  • Respiratory System Agents / pharmacology*

Substances

  • Respiratory System Agents